Anne Roehrig

Anne Roehrig is the Associate Director of International Pricing, Reimbursement, and Access at Eli Lilly and Company. She is responsible for overseeing pricing strategies and ensuring that patients globally have access to Lilly's innovative medicines. Her role involves navigating complex pricing and reimbursement models to optimize patient access while balancing the company's investment in drug development.

Roehrig holds a degree from University College London, which contributes to her expertise in the pharmaceutical industry. She is part of a team that focuses on various pricing strategies that consider market-specific conditions, competitive dynamics, and the value provided to patients and healthcare systems.2

In her position, she likely engages with public policies and advocates for changes that facilitate access to medicines, particularly in low- and middle-income countries (LMICs), where economic challenges can limit patient access to healthcare.1